Look for:

ASTELLAS PHARMA INC.


ISIN:
JP3942400007
WKN:
4503

2024/05/03 22:26:29
Price
9.41 EUR
Difference 0.34% (0.03)

General attributes

ISINJP3942400007
Symbol4503
ExchangeTradegate
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)16,762 EUR
BenchmarkNIKKEI 225

Market data

Bid (Bid size)9.31 EUR (540)
Ask (Ask size)9.508 EUR (529)
Open9.458 EUR
High9.57 EUR
Low9.42 EUR
Close (prev. day)9.378 EUR
VWAP9.50364 EUR
Volume (pcs)2,190
Trading volume20,812.98
Number of trades5
Last size-

Futures and Options

Related Futures-
Related Options-
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/05/03 22:26:29
Price
9.41 EUR
Difference 0.34% (0.03)

General attributes

ISINJP3942400007
Symbol4503
ExchangeTradegate
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)16,762 EUR
BenchmarkNIKKEI 225

Market data

Bid (Bid size)9.31 EUR (540)
Ask (Ask size)9.508 EUR (529)
Open9.458 EUR
High9.57 EUR
Low9.42 EUR
Close (prev. day)9.378 EUR
VWAP9.50364 EUR
Volume (pcs)2,190
Trading volume20,812.98
Number of trades5
Last size-

Performance and Risk

6m1y3y
Perf (%)-20.47%-31.76%-24.31%
Perf (abs.)-2.43-4.39-3.03
Beta0.270.510.61
Volatility26.1326.7826.03
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)9.16 EUR (6,214)
Ø price 30 days | Ø volume 30 days (pcs.)9.47 EUR (2,540)
Ø price 100 days | Ø volume 100 days (pcs.)10.21 EUR (2,086)
Ø price 250 days | Ø volume 250 days (pcs.)12.08 EUR (1,224)
YTD High | date11.46 EUR (2024/01/04)
YTD Low | date8.45 EUR (2024/04/12)
52 Weeks High | date15.64 EUR (2023/05/22)
52 Weeks Low | date8.45 EUR (2024/04/12)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2024/05/0322:269.41 EUR0.025
Tokyo Stock Exchange2024/05/0208:001,558.00 JPY138.365,931
Stuttgart2024/05/0308:029.326 EUR0.003
Munich2024/05/0308:039.368 EUR0.002
Frankfurt2024/05/0321:499.11 EUR0.011
FINRA other OTC Issues2024/04/2621:379.521 USD0.002
Duesseldorf2024/05/0319:319.294 EUR0.007
Berlin2024/05/0321:059.418 EUR0.008

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=3136&ID_TYPE_IMAGE_LOGO=2

Contact Details

ASTELLAS PHARMA INC.
- -
2-5-1 Nihonbashi-Honcho, Chuo-Ku - 103-8411 Tokyo
Telefon: +81-3-3244-3000
Fax: +
E-mail: -

Company Profile

-

Members of Management Board

Kenji YasukawaChairman of Managing Board
Bernie ZeiherMember of Executive Committee
Catherine LevittMember of Executive Committee
Fumiaki SakuraiMember of Executive Committee
Hideki ShimaMember of Executive Committee
Minoru KikuokaMember of Executive Committee
Naoki OkamuraMember of Executive Committee
Yoshihtsugu ShitakaMember of Executive Committee
Yukio MatsuiMember of Executive Committee

Board of directors

Kenji YasukawaChairman of Supervisory Board
Eriko SakuraiMember of Supervisory Board
Haruko ShibumuraMember of Supervisory Board
Hiroko SakaiMember of Supervisory Board
Hiroo SasakiMember of Supervisory Board
Hiroshi KawabeMember of Supervisory Board
Katsuyoshi SugitaMember of Supervisory Board
Mamoru SekiyamaMember of Supervisory Board
Mika NakayamaMember of Supervisory Board
Noriyuki UematsuMember of Supervisory Board
Takashi TanakaMember of Supervisory Board
Tatsuro IshizukaMember of Supervisory Board
Tomokazu FujisawaMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.